02235nas a2200385   4500000000100000008004100001653002100042653001300063653002000076653002800096653002300124653001900147653001100166653001800177653001800195653002800213653002500241100001400266700001400280700001600294700001300310700001300323700001200336700001500348700001500363700001300378700001600391700001700407245010200424856007900526300001000605490000800615520121200623022001401835       2010                            d10aTropical Climate10aTrachoma10aschistosomiasis10aPopulation Surveillance10aParasitic Diseases10aonchocerciasis10aHumans10aHelminthiasis10aHealth policy10aElephantiasis, Filarial10aDeveloping countries1 aBaker M C1 aMathieu E1 aFleming F M1 aDeming M1 aKing J D1 aGarba A1 aKoroma J B1 aBockarie M1 aKabore A1 aSankara D P1 aMolyneux D H00aMapping, monitoring, and surveillance of neglected tropical diseases: towards a policy framework.  uhttp://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(09)61458-6.pdf  a231-80 v3753 a<p>As national programmes respond to the new opportunities presented for scaling up preventive chemotherapy programmes for the coadministration of drugs to target lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminthiasis, and trachoma, possible synergies between existing disease-specific policies and protocols need to be examined. In this report we compare present policies for mapping, monitoring, and surveillance for these diseases, drawing attention to both the challenges and opportunities for integration. Although full integration of all elements of mapping, monitoring, and surveillance strategies might not be feasible for the diseases targeted through the preventive chemotherapy approach, there are opportunities for integration, and we present examples of integrated strategies. Finally, if advantage is to be taken of scaled up interventions to address neglected tropical diseases, efforts to develop rapid, inexpensive, and easy-to-use methods, whether disease-specific or integrated, should be increased. We present a framework for development of an integrated monitoring and evaluation system that combines both integrated and disease-specific strategies.</p>
  a1474-547X